Caligan Partners Lp Top Holdings and 13F Report (2024) About Caligan Partners LpInvestment ActivityCaligan Partners Lp has $2.13 billion in total holdings as of June 30, 2024.Caligan Partners Lp owns shares of 26 different stocks, but just 9 companies or ETFs make up 80% of its holdings.Approximately 13.96% of the portfolio was purchased this quarter.About 13.21% of the portfolio was sold this quarter.This quarter, Caligan Partners Lp has purchased 26 new stocks and bought additional shares in 10 stocks.Caligan Partners Lp sold shares of 3 stocks and completely divested from 5 stocks this quarter.Largest Holdings Liquidia $647,319,259Revolution Medicines $414,562,072ABIVAX SA $207,608,952Vaxcyte $127,225,411Exelixis $84,512,985 Largest New Holdings this Quarter 45258D105 - Immunocore $43,856,815 Holding92790C104 - Viridian Therapeutics $40,303,431 Holding786700104 - SAGIMET BIOSCIENCES INC $19,325,000 Holding04317A107 - ARTIVA BIOTHERAPEUTICS INC $16,840,277 Holding15117F880 - CELLECTAR BIOSCIENCES INC $1,306,594 Holding Largest Purchases this Quarter Revolution Medicines 331,887 shares (about $62.16M)Immunocore 1,381,317 shares (about $43.86M)Viridian Therapeutics 2,193,981 shares (about $40.30M)Aura Biosciences 4,068,384 shares (about $28.89M)AVALO THERAPEUTICS INC 1,528,843 shares (about $28.25M) Largest Sales this Quarter MBX BIOSCIENCES INC 648,590 shares (about $35.80M)Xenon Pharmaceuticals 503,083 shares (about $30.37M)Tyra Biosciences 469,982 shares (about $15.01M) Sector Allocation Over TimeMap of 500 Largest Holdings ofCaligan Partners Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorLQDALiquidia$647,319,2590.0%8,118,89230.5%HealthcareRVMDRevolution Medicines$414,562,072$62,155,797 â–²17.6%2,213,59519.5%HealthcareABIVAX SA$207,608,952$12,792,960 â–²6.6%1,557,9249.8%SPONSORED ADSPCVXVaxcyte$127,225,411$7,435,815 â–²6.2%2,188,6366.0%HealthcareEXELExelixis$84,512,9850.0%1,553,2624.0%HealthcareTNGXTango Therapeutics$78,153,220$2,854,194 â–²3.8%2,500,1033.7%HealthcareAVALO THERAPEUTICS INC$58,468,244$28,253,019 â–²93.5%3,163,8662.8%COM NEWXENEXenon Pharmaceuticals$53,717,020$30,366,090 â–¼-36.1%889,9442.5%HealthcareADMAADMA Biologics$50,429,309$8,106,312 â–²19.2%6,025,0072.4%HealthcareLB PHARMACEUTICALS INC$46,672,5620.0%1,438,0702.2%COM SHSIMCRImmunocore$43,856,815$43,856,815 â–²New Holding1,381,3172.1%HealthcareVRDNViridian Therapeutics$40,303,431$40,303,431 â–²New Holding2,193,9811.9%HealthcareVOR BIOPHARMA INC$35,440,4650.0%1,925,0661.7%COM NEWSAB BIOTHERAPEUTICS INC$31,072,1070.0%7,967,2071.5%COM NEWIVAInventiva$30,856,862$12,051,717 â–²64.1%8,163,1911.5%HealthcareAURAAura Biosciences$30,517,561$28,885,527 â–²1,769.9%4,298,2481.4%HealthcareTYRATyra Biosciences$25,775,133$15,011,225 â–¼-36.8%806,9861.2%HealthcareOPUS GENETICS INC$24,976,815$8,450 â–²0.0%6,077,0841.2%COMANIKAnika Therapeutics$20,995,9520.0%1,435,1301.0%HealthcareSAGIMET BIOSCIENCES INC$19,325,000$19,325,000 â–²New Holding2,500,0000.9%COM SER AARTIVA BIOTHERAPEUTICS INC$16,840,277$16,840,277 â–²New Holding1,736,1110.8%COMFAETH THERAPEUTICS INC$15,736,675$12,586,625 â–²399.6%629,4670.7%COM NEWMBX BIOSCIENCES INC$11,040,000$35,802,168 â–¼-76.4%200,0000.5%COMVERRICA PHARMACEUTICALS INC$5,654,3290.0%923,9100.3%COM SHSAGIOAgios Pharmaceuticals$3,339,9000.0%90,0000.2%HealthcareCELLECTAR BIOSCIENCES INC$1,306,594$1,306,594 â–²New Holding469,9980.1%COM NEWMLYSMineralys Therapeutics$0$75,111,197 â–¼-100.0%00.0%HealthcareCG ONCOLOGY INC$0$60,912,000 â–¼-100.0%00.0%COMSPYRE THERAPEUTICS INC$0$44,292,726 â–¼-100.0%00.0%COM NEWMAZE THERAPEUTICS INC$0$18,356,616 â–¼-100.0%00.0%COMXILIO THERAPEUTICS INC$0$942,996 â–¼-100.0%00.0%COMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
